BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 233 filers reported holding BEAM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,555,769 | +6.6% | 106,269 | +41.5% | 0.01% | +12.5% |
| Q2 2023 | $2,398,071 | +37.7% | 75,104 | +32.1% | 0.01% | +33.3% |
| Q1 2023 | $1,741,421 | -12.6% | 56,872 | +11.6% | 0.01% | -25.0% |
| Q4 2022 | $1,993,437 | +6.4% | 50,970 | +29.5% | 0.01% | 0.0% |
| Q3 2022 | $1,874,000 | -25.0% | 39,347 | -39.0% | 0.01% | -11.1% |
| Q2 2022 | $2,499,000 | +12.4% | 64,556 | +66.4% | 0.01% | +28.6% |
| Q1 2022 | $2,223,000 | -10.9% | 38,796 | +23.9% | 0.01% | 0.0% |
| Q4 2021 | $2,495,000 | +6.5% | 31,308 | +16.3% | 0.01% | 0.0% |
| Q3 2021 | $2,343,000 | -46.4% | 26,926 | -20.7% | 0.01% | -50.0% |
| Q2 2021 | $4,368,000 | +146.5% | 33,938 | +53.3% | 0.01% | +133.3% |
| Q1 2021 | $1,772,000 | – | 22,136 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $189,105,000 | 91.90% |
| PATHWAY CAPITAL MANAGEMENT, LP | 37,399 | $2,993,000 | 16.59% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,390 | $17,960,000 | 10.54% |
| HSG Holding Ltd | 796,089 | $63,719,000 | 4.73% |
| DC Investments Management, LLC | 21,010 | $1,682,000 | 4.17% |
| Monashee Investment Management LLC | 268,820 | $21,516,000 | 3.31% |
| Redmile Group, LLC | 2,532,523 | $202,703,000 | 2.86% |
| HAMILTON LANE ADVISORS LLC | 98,761 | $7,905,000 | 2.58% |
| Alphabet Inc. | 640,792 | $51,289,000 | 2.07% |
| Casdin Capital, LLC | 818,820 | $65,538,000 | 1.95% |